Institute of Agriculture and Biology
Scope
Date
~
-
E-commerce
STIC invests $20 mn in e-commerce giant Tiki
South Korean private equity firm STIC Investments Inc. has invested $20 million in Vietnam’s e-commerce giant Tiki Corporation’s serie...
Nov 17, 2021 (Gmt+09:00)
-
Korean stock market
Seoul commits $204 mn to attract foreign-invested firms by 2026
Foreign-invested enterprises (FIEs) to be set up in Seoul, South Korea from 2022 will receive increased incentives and reduction in office rent, acc...
Nov 11, 2021 (Gmt+09:00)
-
REITs
KTB to launch REITs for logistics centers in Vietnam and housing in US
South Korean asset manager KTB Asset Management Co. plans to launch two overseas real estate investment trusts (REITs) to invest in Vietnam-based lo...
Nov 02, 2021 (Gmt+09:00)
-
ASK 2021
NPS to up strategic partnerships with global institutions
The National Pension Service (NPS) will increase strategic investments with leading global institutional investors to boost overseas alternative inv...
Oct 28, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics-made Moderna vaccine available to Koreans this week
Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...
Oct 27, 2021 (Gmt+09:00)
language -
IPOs
Kakao Pay sets IPO price at top end on heated demand
Kakao Group’s payment services unit Kakao Pay Corp. set the initial public offering price at the top end of the proposed band thanks to strong...
Oct 22, 2021 (Gmt+09:00)
-
IPOs
Simone drops IPO on weak institutional investor demand
South Korean Simone Acc. Collection Ltd. has withdrawn its initial public offering plan on lukewarm demand from institutional investors, investment ...
Oct 21, 2021 (Gmt+09:00)
-
Private equity
STIC raises $25 mn to co-invest in US oil terminal
South Korea's STIC Alternative Co. has raised $25 million to invest in a special purpose company of the Carlyle Group, which owns 50% of an oil expo...
Oct 20, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
COVID-19
Korean govt to spend $1.9 billion to become world’s leading vaccine maker
The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...
Aug 05, 2021 (Gmt+09:00)
-
IPOs
Krafton sets IPO price at top end despite soft institutional demand
South Korean game developer Krafton Inc. set the initial public offering (IPO) price at the top end of the proposed band even as the largest domesti...
Jul 29, 2021 (Gmt+09:00)
-
IPOs
Krafton IPO draws tepid demand from institutional investors
South Korean game developer Krafton Inc.’s initial public offering, the largest domestic IPO in the second half, drew weaker demand from insti...
Jul 28, 2021 (Gmt+09:00)
-
Real estate
Korean funds weigh overseas real estate exits in H2
Domestic office buildings and logistics centers dominated South Korean institutions' property transactions in the first half of this year, with fier...
Jul 14, 2021 (Gmt+09:00)
-
Biosimilars
Celltrion, Samsung Bioepis anticipate increased biosimilar sales in Europe
South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...
Jul 12, 2021 (Gmt+09:00)
-
IPOs
World’s top COVID-19 test kit maker draws $28 bn in IPO subscriptions
The IPO of SD Biosensor Inc., which has sold the most COVID-19 test kits in the world -- selling more than 700 million kits from February 2020 to Ma...
Jul 09, 2021 (Gmt+09:00)
-
Aerospace & Defense
Hanwha to make satellite thrusters with Korea's aerospace institute
Hanwha Corp. will develop the bipropellant thruster, a key component for adjusting the satellite’s position in orbit, together with Korea Aero...
Jun 28, 2021 (Gmt+09:00)
language -
Private debt
Korean institutions ranked top US liquidity provider under 2020 TALF
South Korean institutional investors, including the Public Officials Benefit Association (POBA) and Yellow Umbrella Mutual Aid Fund, emerged as the ...
Jun 17, 2021 (Gmt+09:00)
-
Automobiles
Hyundai tops Korean institutions' May buying list
Hyundai Motor became the key beneficiary of South Korean institutional investors' heavy buying on the local bourse this month as the global chip sho...
May 31, 2021 (Gmt+09:00)
-
COVID-19 vaccines
Samsung Bio plans to manufacture mRNA drug substance from 2022
Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...
May 31, 2021 (Gmt+09:00)
language -
COVID-19
Samsung Biologics to make Moderna’s mRNA vaccine from Q3
Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...
May 23, 2021 (Gmt+09:00)
language -
COVID vaccines
Samsung Biologics in talks to produce Pfizer’s COVID-19 vaccine
South Korea’s Samsung Biologics Co. is in talks with Pfizer Inc.to produce the US drugmaker’s COVID-19 vaccine under a contract manufact...
May 12, 2021 (Gmt+09:00)
language -
ESG
BOK tells institutions to cut exposure in high carbon sectors
The Bank of Korea has asked the country’s financial institutions to reduce exposure in economic sectors that generate high levels of carbon em...
Mar 25, 2021 (Gmt+09:00)
language -
COVID-19
Samsung Biologics’ focused approach pays off in 2020
Samsung Biologics Co. delivered forecast-beating earnings this week, with its sales topping 1 trillion won ($905 million) for the first time in its ...
Jan 27, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
SK in talks to buy French biologics contract manufacturer
SK Holdings is in the early stages of negotiations to acquire France’s biologic contract manufacturing organization (CMO) Yposkesi, in a move ...
Dec 17, 2020 (Gmt+09:00)
language -
Bio earnings
Samsung Biologics Jan-Sept profit beats entire 2019 gains
Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of capacity, posted an operating profit of 200.2 b...
Oct 21, 2020 (Gmt+09:00)
-
Bio
Samsung Biologics to double bioreactor capacity with $1.5 bn new plant
Samsung Biologics Co. Ltd., the world’s largest contract manufacturing organization (CMO) in terms of capacity, will invest 1.74 trillion won ($...
Aug 11, 2020 (Gmt+09:00)
-
Venture capital
Singapore’s Vickers Venture tapping Korean institutions for $500 mn fund
Vickers Venture Partners, a Singapore-based venture capital firm, is tapping South Korean institutional investors in the second round of fundraising t...
May 19, 2020 (Gmt+09:00)
-
Korean institutions to invest $53 mn to buy Tesco-leased UK warehouse
A consortium of South Korea’s Construction Workers Mutual Aid Association (CWMAA) and MG Non-Life Insurance Co. Ltd. will invest 60 billion won ($53...
Oct 20, 2017 (Gmt+09:00)
-
CCIM to Hold International Conference Jointly with KED Real Estate Research Institutes
The Certified Commercial Investment Member, an American association of international real estate investment analysts, will jointly host the Asia Real ...
Jul 18, 2017 (Gmt+09:00)
-
Korean asset firms strive to fund property deals as institutions step back
South Korean investment firms, which have recently snapped up prime office buildings and warehouses in the US and Europe, are struggling to raise capi...
Mar 22, 2017 (Gmt+09:00)